InVivo Therapeutics Holdings Corp. announced that Richard Toselli, M.D., has been appointed President and Chief Executive Officer of InVivo, having been appointed the company's Acting CEO in December 2017. Dr. Toselli also has been appointed to the company's Board of Directors and will continue to serve in his capacity as InVivo's Chief Medical Officer, which role he assumed upon joining the company in July 2017.

Prior to joining InVivo, Dr. Toselli served as Chief Medical Officer for Cochlear Limited. In that role, he was responsible for global clinical, regulatory, and medical affairs teams reporting to the Chief Executive Officer.